Stada Arz names new finance chief

31 January 2020
stada-location-big

German drugmaker Stada Arzneimittel has appointed Wolfgang Ollig as group chief financial officer (CFO) with effect from February 1, 2020.

He succeeds Mark Keatley who joined Stada in 2017, but has decided to step down as CFO for personal reasons.

Dr Ollig, who received his PhD summa cum laude in Business Administration from the University of Regensburg, has more than 15 years of group CFO experience in various industries including medical and automotive.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical